2022 - Research.com Best Female Scientist Award
Member of the European Academy of Sciences and Arts
Her main research concerns Alzheimer's disease, Dementia, Internal medicine, Disease and Pathology. The Alzheimer's disease study combines topics in areas such as Genetics, Genome-wide association study, Central nervous system disease, Degenerative disease and Apolipoprotein E. Her Dementia research includes elements of Cohort study, Gerontology and Risk factor.
Hilkka Soininen has researched Internal medicine in several fields, including Placebo, Endocrinology, Oncology and Cardiology. She studied Disease and Clinical trial that intersect with Biomarker and Neuroimaging. Her Pathology research is multidisciplinary, incorporating elements of Magnetic resonance imaging and Neurology.
Her primary scientific interests are in Dementia, Internal medicine, Disease, Alzheimer's disease and Pathology. Her Dementia research integrates issues from Neurology, Cognition, Cognitive impairment and Gerontology. The various areas that she examines in her Internal medicine study include Endocrinology, Oncology and Cardiology.
Her research in Disease intersects with topics in Biomarker, Genetics, Bioinformatics, Psychiatry and Neuroscience. The Alzheimer's disease study which covers Atrophy that intersects with Temporal lobe. Within one scientific family, Hilkka Soininen focuses on topics pertaining to Magnetic resonance imaging under Pathology, and may sometimes address concerns connected to Neuroimaging.
Her primary areas of study are Dementia, Internal medicine, Disease, Cognition and Cognitive decline. Hilkka Soininen combines subjects such as Gerontology, Cognitive impairment, Intervention, Randomized controlled trial and Neurology with her study of Dementia. Her studies deal with areas such as Endocrinology and Oncology as well as Internal medicine.
She works mostly in the field of Disease, limiting it down to topics relating to Cerebrospinal fluid and, in certain cases, Normal pressure hydrocephalus, as a part of the same area of interest. In Cognition, Hilkka Soininen works on issues like Clinical psychology, which are connected to Neuropsychology. She has included themes like Frontotemporal dementia, Visual analogue scale, Dementia with Lewy bodies, Vascular dementia and Atrophy in her Cognitive decline study.
Hilkka Soininen mainly investigates Dementia, Internal medicine, Cognition, Neurology and Cognitive decline. To a larger extent, Hilkka Soininen studies Disease with the aim of understanding Dementia. Her Internal medicine research includes themes of Endocrinology, Oncology and Cognitive test.
Her Cognition study incorporates themes from Randomized controlled trial, Geriatric psychiatry and Confidence interval. Her biological study spans a wide range of topics, including Insomnia, Cohort, Sleep in non-human animals, Neuropathology and Confounding. In her study, Alzheimer's disease is strongly linked to Episodic memory, which falls under the umbrella field of Cognitive skill.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study.
Miia Kivipelto;Eeva-Liisa Helkala;Mikko P Laakso;Tuomo Hänninen.
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish.
Nature Genetics (2011)
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.
Miia Kivipelto;Tiia Ngandu;Laura Fratiglioni;Matti Viitanen.
JAMA Neurology (2005)
Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease
Suvi Rovio;Ingemar Kåreholt;Eeva-Liisa Helkala;Matti Viitanen.
Lancet Neurology (2005)
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease
Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi.
PLOS ONE (2014)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola;Irina Alafuzoff;Sanna-Kaisa Herukka;Laura Parkkinen.
JAMA Neurology (2009)
Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease'
Peter Davies;Judith Resnick;Burton Resnick;Sid Gilman.
Neurobiology of Aging (1998)
Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study.
Miia Kivipelto;Miia Kivipelto;Miia Kivipelto;Tiia Ngandu;Tiia Ngandu;Tiina Laatikainen;Bengt Winblad;Bengt Winblad.
Lancet Neurology (2006)
Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.
Miia Kivipelto;Eeva-Liisa Helkala;Mikko P. Laakso;Tuomo Hänninen.
Annals of Internal Medicine (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: